Anxiety

Anxiety and depression are prevalent psychiatric comorbidities among individuals with hemophilia, according to study results.

A virtual reality therapy designed to ease anxiety associated with neuroimaging tests for patients with primary brain tumors appeared feasible, according to an interim analysis of a phase 2 clinical trial.

A dietary pattern with high intakes of chocolate, butter, added sugars, high-fat cheese and milk-based desserts along with low intakes of fruit and vegetables was linked to a greater risk for depression and anxiety symptoms, data show.

Use of any benzodiazepine appeared associated with reduced risk for pancreatic cancer-related death, according to study results published in Clinical Cancer Research.

The prevalence of distress among women with late-stage gynecologic cancers calls for well-designed studies to assess the safety and efficacy of psychedelics for this patient population, according to authors of a published commentary.

Medical marijuana appeared to significantly improve chronic pain and anxiety symptoms over the first 3 months of use, according to Michelle R. Lent, PhD.

Mind Medicine Inc. has announced an agreement with Catalent to use its Zydis orally disintegrating tablet technology for development of a new psychedelic-based anxiety treatment, according to a company press release.

Recruitment is underway for a small study focused on the ability of psilocybin to reduce anxiety among individuals with metastatic cancer.

After using smartphone-based multimedia educational aids about preterm birth, pregnant women reported they were more knowledgeable, less anxious and better prepared for decision-making about maternal and infant health, study results show.

A meta-analysis performed by an international group of researchers revealed no association between depression or anxiety and increased overall cancer risk.